A newly derived protein from Bacillus subtilis natto with both antithrombotic and fibrinolytic effects

Journal of Pharmacological Sciences

Volumn 99, Issue 3, 2005, Pages 247-251

  Omura, Kazunobu ^a   Hitosugi, Masahito ^a   Zhu, Xia ^b   Ikeda, Masashi ^a   Maeda, Hiroaki ^b   Tokudome, Shogo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Research and Development Division   (Japan)

Author keywords

Antithrombosis; Bacillopeptidase F; Bacillus subtilis natto; Fibrinolysis; Natto

Indexed keywords

PROTEIN; PROTEIN NKCP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; FIBRINOLYSIS; MALE; NONHUMAN; PROTEIN ANALYSIS; RAT; SOYBEAN;

EID: 28044455866     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0050408     Document Type: Article

References (13)

1. Sumi H, Hamada H, Tsushima K, Mihara H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto: A typical and popular soybean food Japanese diet. Experimenta. 1987;43:1110-1111.
2. Sumi H, Hamada H, Nakanishi K, Hiratani H. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 1990;84:139-143.
3. Fujita M, Nomura K, Hong K, Ito Y, Asada A, Nishimuro S. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem Biophys Res Commun. 1993;197:1340-1343.
4. Choi NS, Yoo KH, Yoon KS, Maeng PJ, Kim SH. Nano-scale proteomics approach using two-dimensional fibrin zymography combined with fluorescent SYPRO ruby dye. J Biochem Mol Biol. 2004;37:298-303.
5. Peng Y, Yang XJ, Xiao L, Zhang YZ. Cloning and expression of a fibrinolytic enzyme (subtilisin DFE) gene from Bacillus amyloliquefaciens DC-4 in Bacillus subtilis. Res Microbiol. 2004;155:167-173.
6. Ko JH, Yan JP, Zhu L, Qi YP. Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02. Comp Biochem Physiol C Toxicol Pharmacol. 2004;137:65-74.
7. Omura K, Kaketani K, Maeda H, Hitosugi M. [Fibrinolytic and anti-thrombotic effect of the protein from Bacillus subtilis (natto) by the oral administration]. J Jpn Soc Biorheol. 2004;18:44-51. (text in Japanese with English abstract)
8. Hara K, Akiyama Y, Tomiuga T, Kobayashi M, Kawashima H. [Interaction of warfarin and vitamin K2 on arterial thrombotic tendency using a rat aorta loop model]. Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi). 1999;113:185-192. (text in Japanese with English abstract)
9. Ronden JE, Groenen-van Dooren MMCL, Hornstra G, Vermeer C. Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains. Atherosclerosis. 1997;132:61-67.
10. Soloma A, Rufo GA, Rudolph CF, Sullivan BJ, Theriault KA, Pero J. Bacillopeptidase F of Bacillus subtilis: purification of the protein and cloning of the gene. J Bacteriol. 1990;172:1470-1477.
11. Xu XC, Nathoo S, Pang AS-H, Carne T, Wong SL. Cloning, genetic organization, and characterization of a structural gene encoding bacillopeptidase F from Bacillus subtilis. J Biol Chem. 1990;265:6845-6850.
12. Roitsch CA, Hageman JH. Bacillopeptidase F: two forms of a glycoprotein serine protease from Bacillus subtilis 168. J Bacteriol. 1983;155:145-152.
13. Pothula A, Serebruany VL, Gurbel PA, McKenzie ME, Atar D. Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease. Eur J Pharmacol. 2000;402:1-10.